Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

✍ Scribed by Confavreux, Christian; O'Connor, Paul; Comi, Giancarlo; Freedman, Mark S; Miller, Aaron E; Olsson, Tomas P; Wolinsky, Jerry S; Bagulho, Teresa; Delhay, Jean-Luc; Dukovic, Deborah; Truffinet, Philippe; Kappos, Ludwig

• Book ID: 121703261
• Publisher: The Lancet
• Year: 2014
• Tongue: English
• Weight: 329 KB
• Volume: 13
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/s1474-4422(13)70308-9